Breaking News
January 19, 2019 - $14.7 million partnership to supercharge vaccine development
January 19, 2019 - Ian Fotheringham receives Charles Tennant Memorial Lecture award
January 19, 2019 - Brain vital signs detect neurophysiological impairments in players with concussions
January 19, 2019 - Lack of job and poor housing conditions increased likelihood of people attending A&E
January 19, 2019 - Novel targeted drug delivery system improves conventional cancer treatments
January 19, 2019 - Rutgers study finds gene responsible for spread of prostate cancer
January 19, 2019 - Complications Higher Than Expected for Invasive Lung Tests
January 19, 2019 - 3-D printed implant promotes nerve cell growth to treat spinal cord injury
January 19, 2019 - Automated texts lead to improved outcomes after total knee or hip replacement surgery
January 19, 2019 - Poor cardiorespiratory fitness could increase risk of future heart attack, finds new study
January 19, 2019 - Drinking soft drinks while exercising in hot weather may increase risk of kidney disease
January 19, 2019 - Formlabs 3D prints anatomical models
January 19, 2019 - Heart-Healthy Living Also Wards Off Type 2 Diabetes
January 19, 2019 - Teaching Kids to Be Smart About Social Media (for Parents)
January 19, 2019 - Metabolite produced by gut microbiota from pomegranates reduces inflammatory bowel disease
January 19, 2019 - Researchers examine how spray from showers and toilets expose us to disease causing bacteria
January 19, 2019 - Behavioral experiments confirm that additional neurons improve brain function
January 19, 2019 - New study compares performance of real-time infectious disease forecasting models
January 19, 2019 - Obesity can be risk factor for developing renal cell carcinoma, confirms study
January 19, 2019 - New regulation designs on cigarette packs direct smokers’ attention to health warnings
January 19, 2019 - QIAGEN receives first companion diagnostic approval in Japan
January 19, 2019 - Study explores role of Dunning-Kruger effect in anti-vaccine attitudes
January 19, 2019 - Newly identified subset of immune cells may be key to fighting chronic inflammation
January 19, 2019 - New immune response regulators discovered
January 18, 2019 - Poor blood oxygenation during sleep predicts chance of heart-related death
January 18, 2019 - First international consensus on the diagnosis and management of fibromuscular dysplasia
January 18, 2019 - Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
January 18, 2019 - Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
January 18, 2019 - Scientists advise caution in immunotherapy research
January 18, 2019 - How children across the world develop language
January 18, 2019 - Columbia Medical Student Receives McDonogh Scholarship
January 18, 2019 - Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
January 18, 2019 - Plant based diet could be the best option for the planet says commission
January 18, 2019 - New conservation practice could reduce nitrogen from agricultural drainage, study shows
January 18, 2019 - UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit
January 18, 2019 - New study determines the fate of DNA derived from genetically modified food
January 18, 2019 - Scientists develop new gene therapy that prevents axon destruction in mice
January 18, 2019 - Study finds critically low HPV vaccination rates among younger adolescents in the U.S.
January 18, 2019 - Brain cells involved in memory play key role in reducing future eating behavior
January 18, 2019 - Risk for Conversion of MS Varies With Different Therapies
January 18, 2019 - Investigational cream may help patients with inflammatory skin disease
January 18, 2019 - Medical school news office receives six writing awards | News Center
January 18, 2019 - County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
January 18, 2019 - Research reveals risk for developing more than one mental health disorder
January 18, 2019 - Scientists discover a dramatic pattern of bone growth in female mice
January 18, 2019 - Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
January 18, 2019 - New nuclear medicine method could improve detection of primary and metastatic melanoma
January 18, 2019 - Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
January 18, 2019 - Health Tip: Don’t Ignore Changes in Skin Color
January 18, 2019 - Dietary Recommendations for Healthy Children
January 18, 2019 - Eliminating the latent reservoir of HIV
January 18, 2019 - Pain From The Government Shutdown Spreads. This Time It’s Food Stamps
January 18, 2019 - Newly discovered regulatory mechanism helps control fat metabolism
January 18, 2019 - New rapid blood tests could speed up TB diagnosis, save the NHS money
January 18, 2019 - Researchers develop intelligent system for ‘tuning’ powered prosthetic knees
January 18, 2019 - Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma
January 18, 2019 - New research detects mosquito known to transmit malaria for the first time in Ethiopia
January 18, 2019 - Researchers identify new genes linked to development of age-related macular degeneration
January 18, 2019 - Computerized method helps better protect pharma patents
January 18, 2019 - New guidelines to make swallowing safer for people in Australian nursing homes
January 18, 2019 - Lumex Instruments’ RA-915AM monitor installed at Hg treatment plant in Almadén, Spain
January 18, 2019 - ACCC survey finds multiple threats to growth of cancer programs
January 18, 2019 - Meeting the challenge of engaging men in HIV prevention and treatment
January 18, 2019 - Furloughed Feds’ Health Coverage Intact, But Shutdown Still Complicates Things
January 18, 2019 - Experts discuss various aspects on health risks posed by fumigated containers
January 18, 2019 - Researchers use gene-editing tool CRISPR/Cas9 to limit impact of parasitic diseases
January 18, 2019 - Alpha neurofeedback training could be a means of enhancing learning success
January 18, 2019 - Innovative ‘light’ method demonstrates positive results in fight against malignant tumors
January 18, 2019 - The cytoskeleton of neurons found to play role in Alzheimer’s disease
January 18, 2019 - New resource-based approach to improve HIV care in low- and middle-income countries
January 18, 2019 - Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board
January 18, 2019 - New study shows link between secondhand smoke and cardiac arrhythmia
January 18, 2019 - DZIF scientists reveal problems with available diagnostics for Zika and chikungunya virus
January 18, 2019 - Breast cancers more likely to metastasize in young women within 10 years of giving birth
January 18, 2019 - Over 5.6 million Americans exposed to high nitrate levels in drinking water
January 18, 2019 - Blood vessels can now be created perfectly in a petri dish
January 18, 2019 - Study identifies prominent socioeconomic and racial disparities in health behavior in Indiana
January 18, 2019 - Young-Onset Type 2 Diabetes Tied to Increased Hospitalization Risk
January 18, 2019 - For-profit nursing schools associated with lower performance on nurse licensure test
January 18, 2019 - Considering the culture of consent in medicine
Modeling Alzheimer’s Disease Using Microfluidics

Modeling Alzheimer’s Disease Using Microfluidics

image_pdfDownload PDFimage_print

An interview with Dr. Joseph Park, Ph.D., discussing the use of microfluidic systems in Alzheimer’s Disease research and the incorporation of microglia into the Alzheimer’s-in-a-dish culture system.

How are microfluidic systems used in research?

Microfluidic systems are tiny devices that have multiple chambers. They are used to mix small quantities of fluids and cells for interaction studies.

Microfluidics system - by science photoImage Credit: science photo / Shutterstock

In our research, we use microfluidic devices with two chambers; one contains neuron cells and astrocytes, and the other contains microglia. The two chambers are connected via migration channels.

When the neuronal cells and astrocytes become activated, they release chemicals that recruit microglia, which then move through the migration channels. Systems like this enable us to study the cell-cell interactions that can identify recruitment factors for the microglial cells.

What is the Alzheimer’s-in-a-dish culture system?

One of the most important things we are doing is culturing cells within 3D gels. This allows the cells to grow into a 3D tissue that is more representative of the human brain than cells grown in a 2D petri dish. We call this the Alzheimer’s-in-a-dish culture system.

As shown by our 2014 paper in Nature, we can entrap an Aβ peptide in this 3D gel and observe the Aβ plaque-like formation in the extracellular region. Furthermore, we were able to mimic the amyloid-beta (Aβ)-driven tau pathology including hyperphosphorylation (pTau) and neurofibrillary tangles (NFTs) which are the hallmarks of the late stage AD. This system will allow us to study and dissect the mechanism of neural-glial cells in a more physiologically-relevant environment.

Were there any drawbacks to the previous system?

The major limitation of this system was the lack of microglia. The human brain parenchyma contains four representative cell types; astrocytes, neurons, oligodendrocytes, and microglia cells, yet our system only contained the first three. This meant that the system we designed wasn’t a true representation of the brain, and any results we obtained weren’t as accurate as they could be.

Microglia are a type of immune cell that defend against pathogens and foreign bodies in the brain and CNS. They have a very important role in disease pathology because they clear dying neurons from the brain and remove toxins. In a balanced system, this works perfectly. However, the chronic activation of microglia results in inflammation and disease.

The role of microglia in Alzheimer’s disease is a controversial topic. Nobody knows whether they have a positive or negative effect, so it was important for us to design a microfluidic system that could incorporate these cells.

Neuronal connection - By Andrii VodolazhskyiImage Credit: Andrii Vodolazhskyi / Shutterstock

Please describe your recent study.

We took our original Alzheimer’s-in-a-dish culture system and added another chamber for microglial cells.

We found that if we cultured neuronal cells with Alzheimer’s disease-like environment (Aβ and NFTs) for more than nine weeks, they begin to secrete several cytokines including MCP1, TNF-α, and IFN-γ.

This cytokine is a potent recruitment signal for microglia, which become activated and damaged neuron/astrocyte inducing cellular death, which we think that may contribute to memory loss in humans.

CC: Central chamber, AC: Angular chamber, MC: Migration channel.

Why are the results of the study so ground-breaking for Alzheimer’s researchers?

Our system provides a new way to screen potential Alzheimer’s drugs. There are more than 3,000 approved compounds that could be used to target Alzheimer’s disease. You cannot screen all of these compounds in human models.

Using our system, scientists can screen molecules quickly in a model that accurately mimics Alzheimer’s disease in the human brain. If any of these compounds reduce microglial cell recruitment, we know that they will reduce neuronal damage.

What are the next steps for your research?

One of the drawbacks of the current system is that we used immortalized microglia cells. So, we are currently looking into ways of using normal and/or AD risk gene mutated microglial cells derived from induced pluripotent stem cells (iPSCs) that can give us a more physiologically relevant system to study microglia and/or glial activation in AD.

We also want to consider the potential of microglial cells as a treatment for Alzheimer’s disease. Let’s say we can use a drug that inhibits the side effects of microglial activation – the death of healthy neurons – and promotes the positive effects; i.e. the removal of amyloid plaques and dying neurons with tau tangles.

To do this, we are investigating whether induced-pluripotent stem cells (IPSCs) can be used to generate microglial cells that clear amyloid plaques.

Where can readers find more information?

About Dr. Joseph Park

My research aims at providing scientific solutions to the latest issues in the neurodegenerative disorder, particularly in Alzheimer’s disease (AD). AD is the leading cause of age-related neurodegenerative disease affecting over 5.2 million people in the United States.

While our knowledge underlying the AD pathogenic mechanism has greatly improved, no cure is available. Recent failures of anti-β-amyloid therapies in humans, which were highly effective in mouse models, might be explained the problematic issue of translating data from animals to human. Therefore, there is a pressing need to develop artificial human AD brain models to study molecular mechanisms for drug development.

My research is focused on (1) the development of in vitro human AD brain on a chip including iPSC-derived microglia, (2) proteomic profiling for the identification molecular pathways triggered by excess amyloid-beta in 3D AD neuron cells.

The aim is to constructively introduce a specific targeted brain area and enhance the physiologically relevant brain environment that conventional approaches cannot achieve.

Tagged with:

About author

Related Articles